Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Europe source : Www.biospace.com save search
Thermo Fisher Scientific Innovations at Analytica 2024 Optimize Workflows and Enable Precise Analysis Across Life Sciences, Applied and Industrial Markets
Published: 2024-04-09 (Crawled : 12:00) - biospace.com/
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: 0.68%
H: 0.98%
C: 0.93%
life
Ligand Pharmaceuticals Announces New Topiramate Injection Data Presented at 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference
Published: 2024-04-08 (Crawled : 13:00) - biospace.com/
LGND | $72.59 0.1% 0.1% 140K
|
Health Technology
|
| O: 1.33%
H: 3.3%
C: 2.72%
conference epilepticus pharmaceuticals injection
Positive Results from Phase 3 OPTIMIZE-1 Trial of Once Daily OCS-01 for the Treatment of Inflammation and Pain Following Cataract Surgery Presented at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting
Published: 2024-04-08 (Crawled : 11:00) - biospace.com/
OCS | $11.78 0.0% 69K
|
n/a
|
| O: 0.36%
H: 0.18%
C: -2.76%
ocs-01 positive treatment for meeting trial results
Calliditas receives notice of allowance for United States patent application covering setanaxib in cancer treatment
Published: 2024-04-08 (Crawled : 09:00) - biospace.com/
CALT | $17.65 -2.4% 4K
|
Health Technology
|
| O: -1.06%
H: 3.5%
C: 0.51%
patent cancer treatment for application
Angle PLC Announces Parsortix HER2 Assay Showcased at AACR 2024
Published: 2024-04-08 (Crawled : 08:00) - biospace.com/
ANPCF | $0.148 641.22% 5K
|
Health Technology
| Email alert
Add to watchlist
ANPCY | $1.98 338.38% 930
|
Manufacturing
| Email alert
Add to watchlist
her2 assay
Innate Pharma Files Its 2023 Universal Registration Document (Document d’enregistrement Universel) and 2023 Annual Report on Form 20-F
Published: 2024-04-05 (Crawled : 11:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.77%
H: 0.0%
C: -1.81%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -3.44%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -0.4%
H: 0.0%
C: -5.22%
pharma report universal
MaaT Pharma Announces Initiation of Coverage of its Stock by Gilbert Dupont/ Groupe Société Générale
Published: 2024-04-05 (Crawled : 09:00) - biospace.com/
BNPQY | $34.61 -2.68% 100K
|
Finance and Insurance
|
| O: -0.04%
H: 0.95%
C: 0.75%
pharma
Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in EuropeCompany’s IP Protection for VAZKEPA® in Europe Now Extended Into 2039
Published: 2024-04-03 (Crawled : 19:00) - biospace.com/
AMRN | News | $0.88 0.94% 0.93% 1M
|
Health Technology
|
| O: 3.03%
H: 8.82%
C: 3.92%
vazkepa europe update
Evaxion and Undisclosed Collaborator Announce Encouraging Results for EVX-B1 Vaccine Antigens Against Staphylococcus Aureus Infection
Published: 2024-04-02 (Crawled : 12:00) - biospace.com/
EVAX | $4.2 -0.47% -0.48% 31K
|
Manufacturing
|
| O: 6.58%
H: 14.71%
C: 14.12%
vaccine infection results
Bicycle Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-02 (Crawled : 12:00) - biospace.com/
BCYC | $23.41 -4.41% -4.61% 550K
|
Health Technology
|
| O: -2.71%
H: 0.65%
C: -1.25%
conference bicycle therapeutics
Stevanato Group Announces Pricing of Upsized Public Offering of Ordinary Shares
Published: 2024-03-22 (Crawled : 08:00) - biospace.com/
STVN | $26.73 -5.88% 0.0% 670K
|
|
| O: -0.74%
H: 11.67%
C: 10.36%
MS | News 0 d | $90.66 0.44% 0.07% 8.1M
|
Finance
|
| O: 0.13%
H: 0.36%
C: -1.68%
group offering
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE
Published: 2024-03-22 (Crawled : 08:00) - biospace.com/
RLFTF | $1.43 11.45% 3.8K
|
n/a
|
| O: -3.07%
H: 18.31%
C: 12.54%
ETON | $3.12 1.96% 1.92% 34K
|
Health Technology
|
| O: 6.08%
H: 5.73%
C: 3.13%
license pharmaceuticals golike therapeutics agreement
Angle PLC Announces Parsortix at European Breast Cancer Conference
Published: 2024-03-22 (Crawled : 08:00) - biospace.com/
ANPCF | $0.148 641.22% 5K
|
Health Technology
| Email alert
Add to watchlist
ANPCY | $1.98 338.38% 930
|
Manufacturing
| Email alert
Add to watchlist
conference breast cancer
AstriVax Rounds Out Executive Team with Chief Business Officer (CBO) Dr. Gregory Fanning
Published: 2024-03-19 (Crawled : 08:00) - biospace.com/
BNPQF | $68.558 -13.4% 400
|
Finance
|
| O: 1.12%
H: 0.0%
C: 0.0%
BNPQY | $34.61 -2.68% 100K
|
Finance and Insurance
|
| O: 0.81%
H: 0.24%
C: -0.47%
business
Innate Pharma Announces Its Participation to Upcoming Investor Conference - March 19, 2024
Published: 2024-03-19 (Crawled : 08:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.51%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 0.84%
H: 4.56%
C: 0.83%
pharma conference
NLS Pharmaceutics to Participate in the BIO-EUROPE Springtime Partnering Event
Published: 2024-03-14 (Crawled : 12:30) - biospace.com/
NLSP | $0.1327 6.04% 74K
|
|
| O: 2.52%
H: 0.0%
C: -4.31%
Jazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on Tuesday, March 19, 2024
Published: 2024-03-12 (Crawled : 22:00) - biospace.com/
JAZZ | $109.96 0.63% 0.63% 760K
|
Health Technology
|
| O: -0.44%
H: 0.59%
C: -0.28%
day pharmaceuticals
Namodenoson Treatment for Pancreatic and Liver Cancer: Data will be Discussed in Out-licensing and Distribution Partnering Meetings at Bio Europe Conference
Published: 2024-03-11 (Crawled : 12:30) - biospace.com/
CANF | $1.99 1.02% -0.5% 7.8K
|
Health Technology
|
| O: -0.45%
H: 2.27%
C: 2.27%
europe liver conference distribution pancreatic treatment namodenoson
KalVista Pharmaceuticals Reports Third Fiscal Quarter Results and Provides Operational Update - March 11, 2024
Published: 2024-03-11 (Crawled : 12:00) - biospace.com/
KALV | $11.59 0.78% 0.78% 350K
|
Health Technology
|
| O: -2.23%
H: 2.85%
C: -6.7%
update pharmaceuticals results
Mallinckrodt Announces Journal Publication of Real-World Data on Acthar® Gel (repository corticotropin injection) to Treat Symptomatic Sarcoidosis in African American and Non-African American Patients
Published: 2024-03-11 (Crawled : 12:00) - biospace.com/
MNK | $0.3402 -0.06% 540K
|
n/a
| Email alert
Add to watchlist
MNKTQ | $0.12 -66.67% 39K
|
Manufacturing
| Email alert
Add to watchlist
MNKPF | $17.25
|
n/a
| Email alert
Add to watchlist
MNKKQ | $0.02
|
Manufacturing
| Email alert
Add to watchlist
acthar publication treat gel
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.